Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 |
| | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
| Revenue | 47,103.0 | 44,836.0 | 45,457.0 | 43,968.0 | 42,586.0 | 39,275.0 | 41,541.0 | 39,065.0 |
| Revenue growth | 10.6% | 14.2% | 9.4% | 12.6% | 16.1% | 0.3% | 4.5% | 4.6% |
| Cost of products sold | 45,498.0 | 43,154.0 | 43,841.0 | 42,326.0 | 41,111.0 | 37,463.0 | 39,765.0 | 37,350.0 |
| Gross margin | 1,605.0 | 1,682.0 | 1,616.0 | 1,642.0 | 1,475.0 | 1,812.0 | 1,776.0 | 1,715.0 |
| Gross margin | 3.4% | 3.8% | 3.6% | 3.7% | 3.5% | 4.6% | 4.3% | 4.4% |
| |
| Operating expenses: | | | | | | | | |
| Distribution, selling, general and administrative expenses | 1,155.0 | 1,137.0 | 1,151.0 | 1,114.0 | 1,129.0 | 1,120.0 | 1,147.0 | 1,137.0 |
| Restructuring and employee severance | 45.0 | 31.0 | 7.0 | 18.0 | 33.0 | 24.0 | 20.0 | 37.0 |
| Amortization and other acquisition-related costs | 87.0 | 79.0 | 79.0 | 79.0 | 106.0 | 111.0 | 116.0 | 118.0 |
| Impairments and (gain)/loss on disposal of assets, net | 286.0 | 471.0 | 1,295.0 | -2.0 | 1.0 | 69.0 | | 9.0 |
| Litigation (recoveries)/charges, net | -4.0 | 61.0 | 34.0 | 18.0 | 44.0 | 15.0 | 32.0 | 1,038.0 |
| Operating earnings/(loss) | 36.0 | -97.0 | -950.0 | 415.0 | 162.0 | 473.0 | 461.0 | -624.0 |
| Operating margin | 0.1% | -0.2% | -2.1% | 0.9% | 0.4% | 1.2% | 1.1% | -1.6% |
| Other (income)/expense, net | 30.0 | 3.0 | -13.0 | -4.0 | -16.0 | -12.0 | -12.0 | -7.0 |
| Interest expense, net | -34.0 | -38.0 | -37.0 | -40.0 | -44.0 | -45.0 | -46.0 | -45.0 |
| Loss on early extinguishment of debt | | | | 10.0 | 13.0 | | | -1.0 |
| Provision for/(benefit from) income taxes | -165.0 | 1,253.0 | -1,022.0 | 97.0 | 4.0 | 320.0 | -203.0 | -410.0 |
| Net earnings | 137.0 | -1,390.0 | 49.0 | 272.0 | 115.0 | 120.0 | 630.0 | -253.0 |
| Less: Net earnings attributable to noncontrolling interests | 1.0 | -1.0 | | -1.0 | 1.0 | -1.0 | -1.0 | |
| Net earnings/(loss) attributable to Cardinal Health, Inc. | 138.0 | -1,391.0 | 49.0 | 271.0 | 116.0 | 119.0 | 629.0 | -253.0 |
| |
| Earnings/(loss) per common share attributable to Cardinal Health, Inc. | | | | | | | | |
| Earnings Per Share, Basic | ($280,999,999.53) | $274,999,994.95 | $279,000,000.17 | $0.94 | ($292,999,999.60) | $292,000,000.41 | $294,000,002.14 | ($0.86) |
| Earnings Per Share, Diluted | ($280,999,999.53) | $274,999,994.95 | $281,000,000.17 | $0.94 | ($293,999,999.60) | $294,000,000.40 | $295,000,002.13 | ($0.86) |
| |
| Weighted-average number of common shares outstanding: | | | | | | | | |
| Basic (in shares) | 279.0 | 275.0 | 279.0 | 287.0 | 292.0 | 292.0 | 294.0 | 293.0 |
| Diluted (in shares) | 279.0 | 275.0 | 281.0 | 289.0 | 294.0 | 294.0 | 295.0 | 293.0 |
|